A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries.

Details

Serval ID
serval:BIB_781F39A88B91
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries.
Journal
European journal of cancer
Author(s)
Belkacemi Y., Grellier N., Ghith S., Debbi K., Coraggio G., Bounedjar A., Samlali R., Tsoutsou P.G., Ozsahin M., Chauvet M.P., Turkan S., Boussen H., Kuten A., Tesanovic D., Errihani H., Benna F., Bouzid K., Idbaih A., Mokhtari K., Popovic L., Spano J.P., Lotz J.P., Cherif A., To H., Kovcin V., Arsovski O., Beslija S., Dzodic R., Markovic I., Vasovic S., Stamatovic L., Radosavljevic D., Radulovic S., Vrbanec D., Sahraoui S., Vasev N., Stojkovski I., Risteski M., Freixa S.V., Krengli M., Radosevic N., Mustacchi G., Filipovic M., Kerrou K., Taghian A.G., Todorovic V., Geara F., Gligorov J.
ISSN
1879-0852 (Electronic)
ISSN-L
0959-8049
Publication state
Published
Issued date
08/2020
Peer-reviewed
Oui
Volume
135
Pages
130-146
Language
english
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Abstract
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a new virus that has never been identified in humans before. COVID-19 caused at the time of writing of this article, 2.5 million cases of infections in 193 countries with 165,000 deaths, including two-third in Europe. In this context, Oncology Departments of the affected countries had to adapt quickly their health system care and establish new organizations and priorities. Thus, numerous recommendations and therapeutic options have been reported to optimize therapy delivery to patients with chronic disease and cancer. Obviously, while these cancer care recommendations are immediately applicable in Europe, they may not be applicable in certain emerging and low- and middle-income countries (LMICs). In this review, we aimed to summarize these international guidelines in accordance with cancer types, making a synthesis for daily practice to protect patients, staff and tailor anti-cancer therapy delivery taking into account patients/tumour criteria and tools availability. Thus, we will discuss their applicability in the LMICs with different organizations, limited means and different constraints.
Keywords
Betacoronavirus/pathogenicity, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/transmission, Coronavirus Infections/virology, Developing Countries/economics, Global Burden of Disease, Humans, Infection Control/economics, Infection Control/organization & administration, Infection Control/standards, Medical Oncology/economics, Medical Oncology/organization & administration, Medical Oncology/standards, Neoplasms/diagnosis, Neoplasms/therapy, Pandemics/prevention & control, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/transmission, Pneumonia, Viral/virology, Poverty, Practice Guidelines as Topic, AROME, COVID-19, Cancer, Guidelines, Health care, LMICs, Recommendations, TRONE
Pubmed
Web of science
Open Access
Yes
Create date
03/07/2020 17:45
Last modification date
28/10/2020 6:27
Usage data